Pentosidine and increased fracture risk in older adults with type 2 diabetes.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMC 2708944)

Published in J Clin Endocrinol Metab on April 21, 2009

Authors

Ann V Schwartz1, Patrick Garnero, Teresa A Hillier, Deborah E Sellmeyer, Elsa S Strotmeyer, Kenneth R Feingold, Helaine E Resnick, Frances A Tylavsky, Dennis M Black, Steven R Cummings, Tamara B Harris, Douglas C Bauer, Health, Aging, and Body Composition Study

Author Affiliations

1: Department of Epidemiology and Biostatistics, University of California, San Francisco, California 94107-1762, USA. Aschwartz@psg.ucsf.edu

Articles citing this

Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int (2010) 2.69

Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci (2010) 1.85

Bone, sweet bone--osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol (2012) 1.73

Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol (2012) 1.30

Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int (2011) 1.25

Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep (2010) 1.18

Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes (2009) 1.17

Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women. Osteoporos Int (2012) 1.13

Type 2 diabetes and bone fractures. Curr Opin Endocrinol Diabetes Obes (2012) 1.12

Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults. J Clin Endocrinol Metab (2010) 1.09

Heterogeneous glycation of cancellous bone and its association with bone quality and fragility. PLoS One (2012) 1.01

Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats. Bone (2013) 0.99

The contribution of collagen crosslinks to bone strength. Bonekey Rep (2012) 0.92

High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control. Osteoporos Int (2014) 0.89

Fracture risk in diabetic elderly men: the MrOS study. Diabetologia (2014) 0.88

Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. J Bone Miner Metab (2010) 0.87

Focal therapeutic irradiation induces an early transient increase in bone glycation. Radiat Res (2014) 0.86

Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO/JngJ mouse. Endocrinology (2014) 0.86

Determinants of bone strength and quality in diabetes mellitus in humans. Bone (2015) 0.85

Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women. Front Endocrinol (Lausanne) (2013) 0.85

Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int (2015) 0.83

Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus. J Bone Miner Res (2015) 0.83

Fracture incidence and risk of osteoporosis in female type 2 diabetic patients in Korea. Diabetes Metab J (2012) 0.82

Low Bone Mass is Associated with Increased Carotid Intima Media Thickness in Men with Type 2 Diabetes Mellitus. Clin Med Insights Endocrinol Diabetes (2013) 0.80

Insulin-like growth factor 1, glycation and bone fragility: implications for fracture resistance of bone. PLoS One (2015) 0.80

Bone fragility in type 2 diabetes mellitus. World J Orthop (2010) 0.80

Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions. Bone Res (2016) 0.79

Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men. Osteoporos Int (2011) 0.79

The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study. J Clin Med Res (2015) 0.79

Childhood obesity, bone development, and cardiometabolic risk factors. Mol Cell Endocrinol (2015) 0.79

Osteoporosis in men with diabetes mellitus. J Osteoporos (2011) 0.78

Advanced Glycation End-products and Bone Fractures. IBMS Bonekey (2009) 0.78

The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol (2014) 0.78

Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study. BMC Musculoskelet Disord (2013) 0.77

Bisphosphonate Treatment in Osteoporosis: Optimal Duration of Therapy and the Incorporation of a Drug Holiday. HSS J (2015) 0.77

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes. Diabetes (2016) 0.76

Bone metabolism and fracture risk in type 2 diabetes mellitus. Bonekey Rep (2012) 0.76

Bone histomorphometry in diabetes mellitus. Osteoporos Int (2015) 0.75

Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosis. Sci Rep (2016) 0.75

Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose. PLoS One (2015) 0.75

Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis. BMC Musculoskelet Disord (2016) 0.75

Advanced Glycation End Products, Diabetes, and Bone Strength. Curr Osteoporos Rep (2016) 0.75

Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics. J Drug Assess (2011) 0.75

Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. Bone (2013) 0.75

Articles cited by this

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07

Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res (1993) 10.98

Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56

Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol (1994) 6.08

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int (2006) 5.50

High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes (1999) 4.59

Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03

Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med (1991) 3.81

Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39

Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27

Age-related changes in the collagen network and toughness of bone. Bone (2002) 3.13

Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab (2008) 3.00

Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab (2007) 1.96

Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures. J Bone Miner Res (1995) 1.93

Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int (2006) 1.87

Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res (2004) 1.64

Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone (2005) 1.53

Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci (2005) 1.45

Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int (2006) 1.41

Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone (2006) 1.39

Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem (2006) 1.36

A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab (2008) 1.26

Prevalent vertebral fractures in black women and white women. J Bone Miner Res (2008) 1.25

Clinical use of bone densitometry: clinical applications. JAMA (2002) 1.19

In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int (2005) 1.19

Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology (Oxford) (2003) 1.16

Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol (1997) 1.08

Vertebral fracture assessment using the lateral scoutview of computed tomography in comparison with radiographs. Osteoporos Int (1998) 1.02

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab (2008) 1.02

Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. Int J Biochem Cell Biol (2004) 0.96

Racial differences in the prevalence of vertebral fractures in older men: the Baltimore Men's Osteoporosis Study. Osteoporos Int (2005) 0.90

Direct quantification of pentosidine in urine and serum by HPLC with column switching. Clin Chem (1996) 0.90

Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. Clin Sci (Lond) (1998) 0.87

High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. Metabolism (2003) 0.86

Articles by these authors

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47

Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2006) 7.38

Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med (2003) 7.25

Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med (2009) 7.06

Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med (2010) 7.03

Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep (2006) 6.98

Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA (2006) 6.93

Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet (2009) 6.66

Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47

Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci (2005) 6.42

Intra-individual change over time in DNA methylation with familial clustering. JAMA (2008) 6.17

Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci (2006) 6.08

Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med (2005) 5.83

Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation (2010) 5.70

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol (2004) 5.26

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA (2011) 5.21

Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20

Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14

Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01

High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004) 4.73

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res (2004) 4.67

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc (2002) 4.55

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

Hearing loss and cognitive decline in older adults. JAMA Intern Med (2013) 4.25

Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care (2003) 4.23

The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med (2005) 4.11

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07

Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc (2003) 4.02

Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci (2002) 4.00

Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97

Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92

Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med (2010) 3.81

Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80

Genome-wide association study of PR interval. Nat Genet (2010) 3.73

Clinical use of bone densitometry: scientific review. JAMA (2002) 3.73

Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med (2006) 3.71

Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68

Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA (2009) 3.62

Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2007) 3.61

Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet (2009) 3.60

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum (2006) 3.60

Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56

Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55

Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med (2003) 3.54

Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care (2008) 3.54

Limited literacy and mortality in the elderly: the health, aging, and body composition study. J Gen Intern Med (2006) 3.51

Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr (2009) 3.44

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr (2005) 3.40

Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37

A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37